Search company, investor...

Pegasus Biologics

pegasusbio.com

Founded Year

2003

Stage

Angel | Alive

Total Raised

$30.2M

About Pegasus Biologics

Pegasus Biologics is developing advanced bioimplants for soft tissue reinforcement for orthopedics, sports medicine, neurosurgical and spine applications

Headquarters Location

6 Jenner Suite 150

Irvine, California, 92618,

United States

949-502-3240

Missing: Pegasus Biologics's Product Demo & Case Studies

Promote your product offering to tech buyers.

Reach 1000s of buyers who use CB Insights to identify vendors, demo products, and make purchasing decisions.

Missing: Pegasus Biologics's Product & Differentiators

Don’t let your products get skipped. Buyers use our vendor rankings to shortlist companies and drive requests for proposals (RFPs).

Pegasus Biologics Web Traffic

Rank
Page Views per User (PVPU)
Page Views per Million (PVPM)
Reach per Million (RPM)
CBI Logo

Pegasus Biologics Rank

Pegasus Biologics Frequently Asked Questions (FAQ)

  • When was Pegasus Biologics founded?

    Pegasus Biologics was founded in 2003.

  • Where is Pegasus Biologics's headquarters?

    Pegasus Biologics's headquarters is located at 6 Jenner, Irvine.

  • What is Pegasus Biologics's latest funding round?

    Pegasus Biologics's latest funding round is Angel.

  • How much did Pegasus Biologics raise?

    Pegasus Biologics raised a total of $30.2M.

  • Who are the investors of Pegasus Biologics?

    Investors of Pegasus Biologics include Life Science Angels, Frazier Healthcare Partners, Three Arch Partners, ONSET Ventures and Affinity Capital Management.

  • Who are Pegasus Biologics's competitors?

    Competitors of Pegasus Biologics include NICO, Biorez, MedShape, Paradigm Spine, Paragon Medical and 12 more.

Compare Pegasus Biologics to Competitors

E
EADevices

EA Devices is developing a high-powered needle for penetrating bone, where the company believes competition is low and present biopsy approaches have known deficiencies (operator control and fatigue, and patient anxiety and pain).

C
Control Medical

Control Medical Technology designs, develops, and markets medical devices to help physicians, nurses, technicians, and other caregivers improve patient care. Its FDA-approved ASPIRE systems are used to remove fluids, tumors, bone, bone marrow, endometrial fluids, blood clots, tissue, and other pathology, targeting unmet clinical needs in oncology, orthopedics, spine, pain management and cardiovascular medicine.

T
Tissue Regeneration Systems

Tissue Regeneration Systems (TRS) is commercializing a skeletal reconstruction and bone reconstruction technology for the fabrication of bioresorbable implants. These implants fully replace themselves with natural bone over time, leaving no residual implanted device; moreover, although the micro-architecture of these implants is porous for the facilitation of bone integration, they can nonetheless bear load and are strong enough to support function without the need for reinforcement from metal plates. Such structural integrity enables them to be used as an alternative to harvested, autologous bone that is fixed with metallic plates for complex skeletal reconstruction. TRS implants are also integrated with an osteoconductive coating that enhances bone regeneration and proliferation; powerful orthobiologics and bone-growing autologous cells will readily bind to this coating, allowing for a controlled biologic release to further accelerate bone formation.

C
Connective Orthopaedics

Connective Orthopaedics is a medical device company focused on the repair of soft tissue injuries.

REGENESIS BIOMEDICAL Logo
REGENESIS BIOMEDICAL

Regenesis is engaged in the development, manufacturing, and sale of biomedical devices that promote healing and skin wound closure more quickly and cost-effectively than existing standards of wound treatment. The company's devices are based on its Cell Proliferation Induction (CPI) technology, in which electromagnetic signals trigger the repair and regeneration of soft tissue cells.

A
Axial Biotech

Axial Biotech, founded in 2002 by a group of spine surgeons and geneticists, is focused on the use of genetics and the development of minimally invasive fusionless devices to advance the diagnosis and treatment of diseases and deformities of the human spine. Axial is a company to pursue DNA-based pre-symptomatic and prognostic tests for common spinal conditions which will augment current clinical and surgical practices. In its initial genetic product development initiative, Axial has made progress towards the discovery of a location in the human genome that is associated with adolescent idiopathic scoliosis. In addition, Axial's founders have developed five motion preserving, fusionless surgical devices (including such device currently being implanted in humans) that have the promise of expanding the current treatable scoliosis patient population by a factor of ten. Axial intends to use its genetic intellectual property in the development of bio-mechanical devices, and to apply its gene discovery/product development methodology to other spinal diseases. Axial (www.axialbiotech.com) is located in Salt Lake City, Utah.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.